Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Dtg Nrtis'

Dtg Nrtis published presentations and documents on DocSlides.

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
DTG-Based Regimens Are Active in INI-Naive Patients With a
DTG-Based Regimens Are Active in INI-Naive Patients With a
by trish-goza
Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
Projecting the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by luanne-stotts
and 22. nd. International AIDS Conference . Sele...
1 Fundación Huésped, Buenos Aires, Argentina;
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
New regimen for $75 a year
New regimen for $75 a year
by tawny-fly
New pricing agreement will speed up access to gen...
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications
by liane-varnes
July 24 2018 . Overview on Safety of HIV Treatmen...
Potential safety issue affecting women living with HIV using
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
10 th International Pediatric HIV Workshop
10 th International Pediatric HIV Workshop
by faustina-dinatale
and 22. nd. International AIDS Conference . Sele...
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.
by liane-varnes
C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
Heather Watts MD Director of HIV Prevention, Program Quality Team
Heather Watts MD Director of HIV Prevention, Program Quality Team
by alida-meadow
Heather Watts MD Director of HIV Prevention, Pro...
1 Queen Mary University, London, United Kingdom;
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
What’s New in WHO Treatment Guidelines
What’s New in WHO Treatment Guidelines
by aaron
July 23 2018 . What We Know About Safety Signals ...
Comparison of INSTI vs EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
The SA National PMTCT Guidelines (2019)
The SA National PMTCT Guidelines (2019)
by cleminal
Outline. The ideal PMTCT pathway . Detail of new i...
Comparison of INSTI vs INSTI
Comparison of INSTI vs INSTI
by mediumgeneral
QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
Paediatric ARV Drug Optimization 3 Review Summary report &
Paediatric ARV Drug Optimization 3 Review Summary report &
by neoiate
*\n\b...
HIV History successes and lessons learned
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
Clinical considerations for the
Clinical considerations for the
by helene
introduction . of . DTG. Nandita Sugandhi. ICAP at...
Meg Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Country Experience in Monitoring New
Country Experience in Monitoring New
by fauna
ARVs: Focus on Toxicity Monitoring . and Surveill...
Neuropsychiatric manifestations and
Neuropsychiatric manifestations and
by Mindbender
sleep disturbances in children and adolescents ran...
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents
by ethlyn
Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
Challenging Cases in Antiretroviral Therapy and Panel Discussion
Challenging Cases in Antiretroviral Therapy and Panel Discussion
by gagnon
Paul E. Sax, MD. Professor of Medicine. Harvard Me...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
The Fast and The Continuous:
The Fast and The Continuous:
by bery
Dolutegravir-based Antiretroviral Therapy Achieves...